Healthcare - Press Releases

Date	Title	Company
21-Aug-2020	Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers	Tiziana Life Sciences plc
21-Aug-2020	Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables	Tecan
20-Aug-2020	Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19	Hercules Pharmaceuticals
20-Aug-2020	Tiziana is Pleased to Retain Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board for an Additional Three-Year Term	Tiziana Life Sciences
20-Aug-2020	New links found between diabetes blood markers and Alzheimer’s disease pathology	University of Eastern Finland
20-Aug-2020	Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease	Tiziana Life Sciences plc
20-Aug-2020	The UK’s biggest innovation network extends its problem-solving prowess to “change the world”	KTN
20-Aug-2020	Sensyne Health announces development of ‘DBm-Health™’ a new software product for people with or at risk of diabetes	Sensyne Health
20-Aug-2020	HARVARD PILGRIM HEALTH CARE, KAIA HEALTH PILOT YIELDS POSITIVE RESULTS IN BACK PAIN RELIEF & SLEEP QUALITY	HARVARD PILGRIM HEALTH CARE
20-Aug-2020	New patient feedback tool for remote consultations	CFEP Surveys
19-Aug-2020	Phase 2/3 trial suggests that AMZELL’s new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective	Amzell
19-Aug-2020	Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology	Ingenza
14-Aug-2020	PTC Therapeutics’ Mary Frances Harmon Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine	PTC Therapeutics, Inc
14-Aug-2020	Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020	Verona Pharma plc
14-Aug-2020	UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc.	UNION therapeutics A/S
14-Aug-2020	Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal	The Sabin Vaccine Institute
14-Aug-2020	Interim Results for the Six Months ended 30 June 2020	Acacia Pharma Group plc
14-Aug-2020	Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study	Bone Therapeutics
14-Aug-2020	Flow depression treatment helps 81% of patients to feel better after three weeks	Flow Neuroscience
13-Aug-2020	Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal	Sabin Vaccine Institute